Tty Biopharm Company Limited (4105) Company Profile


	The Wright Reports site is no longer hosted or operated by Manta. Please review the following: 1. You have been redirected to CorporateInformation.com where you can view Snapshot reports or purchase Wright reports or subscriptions of your choosing. 2. If you were previously linking to Wright Reports please change your links to www.corporateinformation.com 3. If you are a paid subscriber with an active subscription please continue on to the member site: http://member.corporateinformation.com/home.asp 4. For additional information related to CorporateInformation.com please contact help@corporateinformation.com, Contact phone nr to be provided later)

Tty Biopharm Company Limited Company Snapshot

Business Description:

Tty Biopharm Company Limited operates in the Medicinals and botanicals sector. TTY BIOPHARM COMPANY LIMITED is principally engaged in the manufacture, processing and distribution of drugs. The Company provides cardiovascular medicines, orthopedics medicines, gastrointestinal medicines, anti-infection medicines and tumor medicines, among others, including oral solutions and pastes. The Company's products include Lipo-Dox, UFUR, Thado, Oxalip, Asadin, Gemmis, Epicin, Tyxan, Irino, Anazo, Zobonic, Cubicin, Maxtam, Exacin, Metacin and Emangain, among others. The Company distributes its products primarily in Taiwan and the rest of Asia. During the year ended December 31, 2010, the Company obtained approximately 63.14% of its total revenue from the sale of oral medical preparations. In our complete report available for purchase the company is compared to: Yung Shin Pharmaceutical Company Limited, Maywufa Company Ltd. and China Chemical and Pharmaceutical Company Limited.

Tty Biopharm Company Limited

Stock Data:

Recent Stock Performance:

Current Price (2/3/2012): 107.50
(Figures in Taiwanese Dollars)

1 Week	n/a	13 Weeks	23.0%

4 Weeks	10.5%	52 Weeks	n/a

Tty Biopharm Company Limited Key Data:

Ticker:	4105	Country:	TAIWAN

Exchanges:	TAI	Major Industry:	Drugs, Cosmetics & Health Care

		Sub Industry:	Ethical Drug Manufacturers

2010 Sales	3,437,522,000 (Year Ending Jan 2011).	Employees:	N/A

Currency:	Taiwanese Dollars	Market Cap:	18,551,664,150

Fiscal Yr Ends:	December	Shares Outstanding:	172,573,620

Share Type:	Gu	Closely Held Shares:	N/A

Feedback | Terms and Conditions | Privacy Policy | Site Index

CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.